Actionable news
All posts from Actionable news
Actionable news in CLDX: Celldex Therapeutics, Inc.,

Top 2 Trade Alerts For Today - CTI Biopharma And Celldex

These are trade alerts I posted for my subscribers recently. One covers CTI Biopharma (NASDAQ:CTIC) and the other covers Celldex (NASDAQ:CLDX).

Apparently, this is CTIC's office - nice digs!

I have been following CTIC for a while, and I am very excited about the data coming out of its MF trial, especially for patients with lower platelet counts, or thrombocytopenia. That is a major market where Jakafi has no traction, creating an unmet need which CTIC may possibly address.

Considering that, it is important that CTI Biopharma just initiated rolling submission of U.S. NDA for its MF drug candidate pacritinib. This is a major milestone for the company. If approved, pacritinib could achieve peak sales of $320 million in the U.S. alone.

CTIC has a collaboration agreement in place with Baxalta (NYSE:BXLT) to commercialize the drug. Pacritinib could generate peak sales of around $200 million for CTIC based on...